ZYVAC MMR

ZyVac MMR is a combination vaccine that provides protection against three highly contagious viral diseases: measles, mumps, and rubella. This vaccine is an essential part of pediatric immunization schedules, helping to prevent serious complications associated with these infections.

How It Works

ZyVac MMR contains live, attenuated (weakened) viruses that stimulate the immune system to develop immunity against measles, mumps, and rubella. By introducing the body to these weakened viruses, the vaccine helps build a strong defense without causing the diseases themselves. The strains are Edmonston Zagreb of Measles, Hoshino of Mumps, RA27/3 strain of Rubella

Administration

• Primary Dose: Typically administered as a single dose at 9-12 months of age.
• Booster Dose: A second dose is usually given between 15-18 months of age to ensure long-term protection. Second dose must be given in the Second year or 4-8 weeks after the first dose. Third dose is given at 4-6 yrs of age. Total 3 doses as per IAP
• Administration Site: Given as a subcutaneous injection, usually in the upper arm or thigh.

Side Effects

Common side effects may include:

• Mild rash or fever
• Swelling or redness at the injection site
• Temporary joint pain (more common in adults)

Severe reactions are extremely rare.

Pregnancy and Lactation

• Pregnancy: Not recommended during pregnancy. Women of childbearing age should avoid pregnancy for at least one month after receiving the vaccine.
• Lactation: Generally safe for breastfeeding mothers, but should be discussed with a healthcare provider.

Minimum Age Group

• Minimum Age: Approved for use in infants starting at 9 months old.

Contraindications

• Allergic Reactions: Not recommended for individuals with severe allergies to any component of the vaccine, including gelatin or neomycin.
• Severe Immunodeficiency: Not suitable for individuals with severe immunodeficiency or those undergoing treatments that suppress the immune system. Patient on steroids,immunomodulators, alkylating agents, antimetabolites, SCID.
• Severe Illness: Vaccination should be postponed in cases of acute, severe febrile illness.

ZyVac MMR is a critical vaccine in preventing the spread of measles, mumps, and rubella, ensuring that children are protected from these potentially serious diseases. It plays a vital role in maintaining public health and preventing outbreaks. Always consult healthcare providers for detailed vaccination schedules and personalized advice.